MORAN, EVA

MORAN, EVA  

48 - Dipartimento di Medicina Interna e Specialita mediche (DIMI) (attivo dal 01/01/1997 al 18/07/2012)  

Mostra records
Risultati 1 - 20 di 25 (tempo di esecuzione: 0.275 secondi).
Titolo Data di pubblicazione Autore(i) File
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 1-gen-2011 Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 1-gen-2011 Bello, C; Dal Bello, G; Cea, Michele; Nahimana, A; Aubry, D; Garuti, Anna; Motta, Giulia; Moran, Eva; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Zimmermann, K; Loretan, J; Wartmann, M; Duchosal, Ma; Nencioni, Alessio; Vogel, P.
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 1-gen-2009 Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco
APO866 activity in hematologic malignancies: a preclinical in vitro study. 1-gen-2009 Cea, Michele; Zoppoli, Gabriele; Bruzzone, Santina; Fruscione, Floriana; Moran, Eva; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Casciaro, S; Olcese, F; Pierri, Ivana; Cagnetta, Antonia; Ferrando, Fabio; Ghio, Riccardo; Gobbi, Marco; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 1-gen-2009 Bruzzone, Santina; Fruscione, Floriana; Morando, Sara; Ferrando, Tiziana; Poggi, A.; Garuti, Anna; D'Urso, A.; Selmo, M.; Benvenuto, Federica; Cea, Michele; Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Ballestrero, Alberto; Sordat, B.; Patrone, Franco; Mostoslavsky, R.; Uccelli, Antonio; Nencioni, Alessio
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 1-gen-2009 Bruzzone, Santina; Fruscione, Floriana; Morando, Sara; Ferrando, Tiziana; Poggi, A.; Garuti, Anna; Cea, Michele; Moran, Eva; Uccelli, Antonio; Nencioni, Alessio
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 1-gen-2011 Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. 1-gen-2011 Motta, Giulia; Cea, Michele; Carbone, Federico; Augusti, Valeria; Moran, Eva; Patrone, Franco; Nencioni, Alessio
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 1-gen-2009 Uccelli, A; Bruzzone, S; Fruscione, F; Morando, S; Ferrando, T; Poggi, Alessandro; Garuti, A; Selmo, M; Benvenuto, F; Cea, M; Zoppoli, G; Moran, E; Vogel, P; Sordat, B; Ballestrero, A; Patrone, F; Nencioni, A
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 1-gen-2010 Nencioni, Alessio; Cea, Michele; Garuti, Anna; Passalacqua, Mario; Raffaghello, L.; Soncini, Debora; Moran, Eva; Zoppoli, Gabriele; Pistoia, V.; Patrone, Franco; Ballestrero, Alberto
Immunotherapy with dendritic cells for cancer 1-gen-2008 Ballestrero, Alberto; Boy, D.; Moran, Eva; Cirmena, Gabriella; Brossart, P.; Nencioni, Alessio
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 1-gen-2009 Cea, M; Cagnetta, Antonia; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Moran, Eva; Grillo, V; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 1-gen-2010 Motta, Giulia; Cea, Michele; Moran, Eva; Carbone, Federico; Augusti, Valeria; Patrone, Franco; Nencioni, Alessio
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 1-gen-2012 Tortolina, Lorenzo; Castagnino, N; De Ambrosi, C; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Parodi, Silvio
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 1-gen-2010 Bello, C; Cea, Michele; Bello, Gd; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Moran, Eva; Nahimana, A; Duchosal, Ma; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Nencioni, Alessio; Vogel, P.
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 1-gen-2010 Ballestrero, Alberto; Cirmena, Gabriella; Dominietto, A; Garuti, Anna; Rocco, Ilaria; Cea, Michele; Moran, Eva; Nencioni, Alessio; Miglino, Maurizio; Raiola, Am; Bacigalupo, A; Patrone, Franco
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 1-gen-2009 Zoppoli, Gabriele; Cea, Michele; Fruscione, Floriana; Bruzzone, Santina; Soncini, Debora; Bedognetti, D.; Moran, Eva; Balleari, E.; Bruzzone, A.; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Gobbi, Marco; Ghio, Riccardo; Pommier, Y.; Carella, A. M.; Ballestrero, Alberto; Parodi, Silvio; Patrone, Franco; Nencioni, Alessio
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 1-gen-2010 Zoppoli, Gabriele; Cea, Michele; Soncini, Debora; Fruscione, Floriana; J., Rudner; Moran, Eva; Caffa, Irene; D., Bedognetti; Motta, Giovanni; Ghio, Riccardo; Ferrando, Fabio; Ballestrero, Alberto; Parodi, Silvio; C., Belka; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 1-gen-2012 Moran, Eva; Carbone, Federico; Augusti, Valeria; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
Ras-induced resistance to lapatinib is overcome by MEK inhibition 1-gen-2010 Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Cea, Michele; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Grillo, V; Bagnasco, Luca; Icardi, Giancarlo; Ansaldi, Filippo; Parodi, Silvio; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio